Displaying items by tag: equities

Over the past year, the U.S. stock market has risen by an impressive 30%, despite a recent 2.1% drop. This robust growth highlights opportunities in high-growth tech stocks that excel in innovation and scalability. 

Companies like PowerFleet stand out, forecasting a 29.7% annual revenue growth and significant earnings improvement due to strategic expansions such as its Fleet Complete acquisition. Live Nation Entertainment also shines, with substantial revenue driven by concerts, ticketing, and sponsorships, leveraging its global presence to dominate the live entertainment industry. 

Meanwhile, Triumph Group has gained investor attention with a 66.9% one-year stock increase, supported by upward earnings revisions and strong fundamentals. 

Finsum: These examples underscore the dynamic potential of select tech and entertainment stocks in the current market.

The healthcare sector faced significant turbulence following President-elect Donald Trump’s announcement of Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Kennedy’s longstanding skepticism about vaccines has sparked concerns about its impact on public health and industry stability, leading to sharp declines in shares of vaccine producers like Moderna and Pfizer. 

Analysts suggest his leadership could reshape regulatory frameworks, adding uncertainty for pharmaceutical companies and possibly affecting vaccine uptake. Biotech firms also saw notable losses, while psychedelic therapy companies experienced gains, bolstered by Kennedy’s apparent openness to advancing their approval process. 

Meanwhile, the medical technology sector showed relative resilience, though experts caution that indirect impacts could still emerge. As Kennedy prepares to oversee critical agencies like the FDA and CDC, the industry braces for policy changes that could redefine its landscape.

Finsum: Don’t undersell the impact of inertia in regulatory process and now one might capitalize on a dip in health stocks. 

Small-cap stocks in the U.S. have seen significant gains following Donald Trump’s presidential election victory, fueled by optimism over his economic policies. The Russell 2000 index surged about 6% since the election, outperforming major benchmarks, as investors anticipate benefits from tax cuts, deregulation, and increased tariffs that favor domestic businesses. 

However, concerns are growing that these same policies could stoke inflation, potentially leading to higher borrowing costs for small-cap companies heavily reliant on debt. Analysts note that the Federal Reserve may adjust its pace of rate cuts, further challenging the sector’s growth prospects. 

Despite the Russell 2000’s near 19% gain this year, its valuation—trading at 28.3 times forward earnings—remains high compared to the S&P 500. Experts suggest waiting for market pullbacks before adding small-cap stocks to portfolios.

Finsum: We think when adding small caps to consider the value play in addition to size, lower P/E might have a more long lasting performance.

Preferred stocks with a $25 par value, which trade on the New York Stock Exchange, have gained popularity but yield just 5% to 5.5% for major banks, a modest premium over the 30-year Treasury. 

According to Nuveen portfolio manager Douglas Baker, economic resilience and an anticipated soft landing make bank-issued preferreds more appealing, despite limited issuance due to banks’ reduced need for capital. Issuers have redeemed more than they’ve issued this year, tightening supply in the $25-par market, which has seen a 13.1% gain year-to-date. 

Baker points out that tax advantages, high yields, and stock-like trading add to preferreds' appeal. However, their perpetual nature and redemption rights limit price gains and increase sensitivity to rising rates. 

Finsum: There is strong demand for these types of unusual but tax efficient investments in the wider market.

The Fidelity Trend Fund (FTRNX) is a top-rated global equity mutual fund, managed by Shilpa Mehra, with $3.25 billion in assets. Over the past five years, it has delivered strong returns, with an annualized rate of 18.98%, placing it in the top third of its category. 

Although slightly more volatile than its peers, with a 5-year beta of 1.13, it has consistently outperformed benchmarks, producing a positive alpha of 2.74. The fund's expense ratio of 0.55% is notably lower than the category average, making it cost-effective for investors. 

With 80.17% of its portfolio in stocks, primarily in the technology and retail sectors, the fund actively manages its assets with a 50% turnover rate. Overall, FTRNX offers strong performance, reasonable risk, and lower fees, making it an appealing choice for global equity investors.

Finsum: With the upcoming election, investors might consider the viability of international equity exposure in Trend funds such as these.